Business & Finance
Sanofi declares Kiadis offer unconditional
14 April 2021 - French pharmaceutical company Sanofi (Euronext: SAN and NYSE: SNY) and Netherlands-based Kiadis (Euronext Amsterdam and Brussels: KDS) announced on Tuesday that a total of 95.03% of th...
Novo Integrated Sciences incurs net loss of USD1.34m in Q2 fiscal 2021
7 April 2021 - Healthcare company Novo Integrated Sciences Inc (NASDAQ:NVOS) disclosed on Tuesday that it recorded a net loss of USD1.34m for its fiscal 2021 second quarter period ended 28 February 20...
GeNeuro incurs lower net loss of EUR8.96m for 2020
6 April 2021 - Biopharmaceutical company GeNeuro (Euronext Paris:CH0308403085 – GNRO) stated on Monday its net loss of EUR8.96m (EUR0.45 basic losses per share) for the year ended 31 December 20...
HitGen, BioAge Tout Research Progress in DNA-Encoded Library Based Drug Discovery Research Collaboration
...
Liminal BioSciences reports 2020 financial results
25 March 2021 - Liminal BioSciences Inc (Nasdaq: LMNL), a clinical-stage biopharmaceutical company, reported on Wednesday its financial results for the year ended 31 December 2020.The company reported...
AHF announces restart of AstaZeneca Vaccine across the EU after temporary suspension due to concerns about rare adverse reactions
19 March 2021 - HIV/AIDS company AIDS Healthcare Foundation (AHF) stated on Thursday that many nations across the EU countries plan to restart the AstraZeneca vaccinations following European Medicines...